| __timestamp | ADMA Biologics, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 461543000 |
| Thursday, January 1, 2015 | 7015946 | 634806000 |
| Friday, January 1, 2016 | 7688238 | 661905000 |
| Sunday, January 1, 2017 | 6229587 | 610753000 |
| Monday, January 1, 2018 | 3926120 | 696328000 |
| Tuesday, January 1, 2019 | 2343848 | 715007000 |
| Wednesday, January 1, 2020 | 5907013 | 628116000 |
| Friday, January 1, 2021 | 3646060 | 628793000 |
| Saturday, January 1, 2022 | 3613764 | 649606000 |
| Sunday, January 1, 2023 | 3300000 | 746773000 |
| Monday, January 1, 2024 | 747184000 |
Unleashing the power of data
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial. Over the past decade, BioMarin Pharmaceutical Inc. has consistently outpaced ADMA Biologics, Inc. in R&D spending. In 2023, BioMarin's R&D expenses were approximately 75 times higher than ADMA's, highlighting its robust commitment to innovation.
From 2014 to 2023, BioMarin's R&D spending grew by about 62%, peaking at nearly $747 million in 2023. In contrast, ADMA's R&D expenses saw a decline of around 65% over the same period, dropping to $3.3 million in 2023. This disparity underscores BioMarin's strategic focus on developing groundbreaking therapies, while ADMA appears to be more conservative in its R&D investments.
As the biotech industry evolves, these spending patterns may influence each company's ability to innovate and capture market share.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and BioMarin Pharmaceutical Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: BeiGene, Ltd. vs ADMA Biologics, Inc.
Dr. Reddy's Laboratories Limited or ADMA Biologics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Exelixis, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
ADMA Biologics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs MorphoSys AG: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending